Clinical trial
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old…
NCT00463437 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00463437 |
|---|---|
| Title | Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines |
| Official title | Booster Vaccination With Pneumococcal Vaccine GSK1024850A, a DTPa-Combined and MenC or Hib-MenC Vaccines |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Acellular Pertussis, Tetanus, Poliomyelitis, Diphtheria, Streptococcus Pneumoniae Vaccines |
| Intervention type | Biological |
| Interventions | Pneumococcal conjugate vaccine GSK1024850A, Prevenar, Infanrix hexa, Infanrix IPV Hib, Infanrix penta, Infanrix IPV, Meningitec, NeisVac-C, Menitorix |
| Enrollment | 1,437 |
| Start date | Apr 25, 2007 |
| Primary completion | Jan 21, 2008 |
| Completion | Jun 14, 2008 |
| First posted | Apr 20, 2007 |
| Last update posted | Jan 2, 2020 |
| Countries | Germany, Poland, Spain |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: